"Adult" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
| Descriptor ID |
D000328
|
| MeSH Number(s) |
M01.060.116
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adult".
Below are MeSH descriptors whose meaning is more specific than "Adult".
This graph shows the total number of publications written about "Adult" by people in this website by year, and whether "Adult" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 289 | 289 |
| 1997 | 0 | 286 | 286 |
| 1998 | 0 | 291 | 291 |
| 1999 | 0 | 289 | 289 |
| 2000 | 0 | 372 | 372 |
| 2001 | 0 | 360 | 360 |
| 2002 | 0 | 407 | 407 |
| 2003 | 0 | 391 | 391 |
| 2004 | 0 | 453 | 453 |
| 2005 | 0 | 478 | 478 |
| 2006 | 0 | 527 | 527 |
| 2007 | 0 | 562 | 562 |
| 2008 | 0 | 631 | 631 |
| 2009 | 0 | 584 | 584 |
| 2010 | 0 | 618 | 618 |
| 2011 | 0 | 725 | 725 |
| 2012 | 0 | 770 | 770 |
| 2013 | 0 | 795 | 795 |
| 2014 | 0 | 819 | 819 |
| 2015 | 0 | 837 | 837 |
| 2016 | 0 | 908 | 908 |
| 2017 | 0 | 919 | 919 |
| 2018 | 0 | 986 | 986 |
| 2019 | 0 | 971 | 971 |
| 2020 | 0 | 925 | 925 |
| 2021 | 0 | 826 | 826 |
| 2022 | 0 | 393 | 393 |
| 2023 | 0 | 455 | 455 |
| 2024 | 0 | 956 | 956 |
| 2025 | 0 | 1039 | 1039 |
| 2026 | 0 | 504 | 504 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adult" by people in Profiles.
-
What is the Rate of Occult Vessel Abnormalities in High-Energy Tibial Plateau Fractures (OTA/AO 41)? J Orthop Trauma. 2026 Oct 01; 40(10):555-560.
-
Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial. J Bone Miner Res. 2026 Sep 24; 41(10):1069-1079.
-
Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis. Blood Adv. 2026 09 22; 10(18):6188-6197.
-
Characterizing intradural spinal metastasis in the metastatic cascade: clinical course, dissemination timing, and molecular features in 69 patients. J Neurooncol. 2026 Sep 18; 179(3).
-
Digenic HNF1A and ABCC8 variants provide mechanistic insight into early-onset diabetes. J Clin Endocrinol Metab. 2026 Sep 16; 111(10):2827-2836.
-
The Genomic Landscape of MYC-, MYCL-, and MYCN-Amplified Solid Tumors. Clin Cancer Res. 2026 Sep 15; 32(18):4124-4135.
-
Placentas from healthy women living in a cutaneous leishmaniasis endemic region in Mexico harbor Leishmania mexicana parasites: Potential implications for pregnancy and neonatal outcomes. PLoS Negl Trop Dis. 2026 Sep; 20(9):e0014367.
-
The influence of HLA matching on graft survival in lung transplant recipients is indication specific: a UNOS database analysis. Eur Respir J. 2026 Sep; 68(3).
-
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma. Blood Adv. 2026 09 08; 10(17):5778-5788.
-
Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL. Blood Adv. 2026 09 08; 10(17):5821-5827.